1-(4-Fluorobenzoyl)-4-hydroxy-2-pyrrolidinecarboxylic acid, 1g

1,2-Dimethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-imidazole, 98+%, 250mg

3,5-Dihydroxybenzoic acid, 97.0%, 100g

(4-(Prop-2-yn-1-ylcarbamoyl)phenyl)boronic acid, 95.0%, 1g

Fmoc-L-Lysine, PEPTIPURE®, min. 98%, for biochemistry, 1 g, glass packaging

Nalpha-[(9H-Fluoren-9-ylmethoxy)carbonyl]-O-tert-butyl-D-tyrosine>98.0%(HPLC)(T)5g

11-Chloro-2-methyl-2,3,3a,12b-tetrahydro-1H-dibenzo[2,3:6,7]oxepino[4,5-c]pyrrol-1-one, 95%, 250mg

3-hydroxy-6-methyl-2-pyridinecarbaldehyde, 95.0%, 250mg

[1-(2,2,2-trifluoroethyl)-1H-pyrazol-4-yl]methanol, 500mg

[2-(2,6-dimethylphenoxy)ethyl]amine hydrochloride, 95.0%, 250mg

5,6-Dichloro-N-(2,4-dimethoxybenzyl)-N-(thiazol-2-yl)pyridine-3-sulfonamide, 95%, 100mg

6-Bromo-4-hydroxy-2-(trifluoromethyl)quinoline, 95.0%, 25g

Methyl 2-amino-5-methyl-4-(trifluoromethyl)benzoate, 95.0%, 5g